# The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.

> **NCT04417972** · PHASE1,PHASE2 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 179 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** SHR7280
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04417972
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-30
- **Primary completion:** 2024-05-14
- **Final completion:** 2024-05-14
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04417972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04417972, "The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04417972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*